GENE ONLINE|News &
Christine Detrick to Become Lead Independent Director of Charles River Associates in July 2026
Charles River Associates (CRA) has announced that Christine Detrick, a current member of its Board of Directors, will assume the role of Lead Independent Director effective July 16, 2026. The company disclosed this decision in a statement released on April 2, 2026.
Detrick has been serving as a director at CRA and brings extensive experience to her new position. The appointment reflects the company’s ongoing commitment to strong corporate governance practices. No additional details regarding the transition or related changes were provided in the announcement.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 2, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
